Expert Review of Clinical Immunology

Article	Citations
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	89
Pepsin, trypsin, and MUC5B are independent risk factors for hearing impairment in patients with laryngopharyngeal reflux-related chronic secretory otitis media	81
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	70
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	49
CAR-T cell immunotherapy of malignant melanoma	43
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review	42
Full consideration of the pollen exposure effect in clinical trial design for pollen-induced allergic rhinitis	39
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	36
How could our genetics impact COVID-19 vaccine response?	34
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	34
Why is the antigen uptake receptor DEC205 (CD205) of interest?	33
Immunobiology and treatment of cutaneous T-cell lymphoma	33
Bimekizumab for the treatment of psoriatic arthritis	32
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	32
A critical review of dupilumab for adult patients with prurigo nodularis	32
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	31
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	28
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	28
Food immunotherapy: current status and future needs	27
How to and should we target EBV in MS?	27
Inflammatory bowel disease and primary sclerosing cholangitis: immunological links and clinical outlook	26
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	26
Drug development in systemic sclerosis: novel therapeutics to watch	24
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	24
Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis	23

Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	22
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	21
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	21
Neurological adverse effects of chimeric antigen receptor T-cell therapy	21
Impact of anti-PD1 immunotherapy and circulating tumor cells on progression-free survival in surgical pancreatic adenocarcinoma: a retrospective cohort study	20
Rare forms of inflammatory myopathies – part I, generalized forms	20
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults	20
Durability and long-term outcomes of biologic therapies in psoriasis	20
Next-generation sequencing reveals genetic heterogeneity in MEFV -negative or heterozygous familial Mediterranean fever: a retrospective study	19
An exercise immune fitness test to unravel mechanisms of Post-Acute Sequelae of COVID-19	19
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives	19
Transcriptional regulation of B cell class-switch recombination: the role in development of noninfectious complications	18
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps	18
Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis	18
How do nuclear factor kappa B (NF-κB)1 and NF-κB2 defects lead to the incidence of clinical and immunological manifestations of inborn errors of immunity?	17
Inflammatory myopathy in adults, health-related quality of life, and wellbeing: a round trip between immune disease and wellness	17
Is the impact of malaria infection on immune memory of a clinical concern?	17
T-lymphocyte depleted transplants for inborn errors of immunity	17
Reconsidering the interpretation of polyautoimmunity in chronic immune-mediated neuropathies: association, misclassification, and clinical implications	17
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors	16
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity	16
Eradicating measurable residual disease via immunotherapy to cure acute lymphoblastic leukemia: current status and future directions	16
Pathophysiology and management of Staphylococcus aureus in nasal polyp disease	16
Recent insights into comorbidities in atopic dermatitis	16
IL-17A in psoriatic arthritis: mechanistic insights, clinical implications, and advances in therapeutic strategies	16
The intratumor microbiome and cancer immunity: from pathogenesis to therapeutic opportunities through artificial intelligence	15
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management	15
Personalization of therapy for patients with eosinophilic esophagitis	15
Old and new autoantibodies in systemic lupus erythematosus	15
Infectious disease screening in rheumatological patients: a narrative review on methods, risk stratification and clinical management	15
The functional role and the clinical application of periostin in chronic rhinosinusitis	15
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions	15
Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?	15
The role of interleukins in pathogenesis and prognosis of atrial fibrillation	14
Toward a personalized therapy of still’s disease based on immunologic endotypes: a narrative review	14
Advances in tumor immunotherapy targeting macrophages	14
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis	14
Glucocorticoid in systemic lupus erythematosus: the art beyond science	14
Insights into the immunological links between dietary habits and asthma	13
Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success	13
Translational approaches to childhood inflammatory brain diseases: a review	13
Pregnancy and reproductive care in Behçet’s disease: clinical excellence across the maternal journey	13
Diagnostic accuracy of QuantiFERON-TB gold plus with chemiluminescence immunoassay: a systematic review and meta-analysis	13
Updates in toxicities associated with immune checkpoint inhibitors	13
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation	13
Temporal trends in anaphylaxis ED visits over the last decade and the effect of COVID-19 pandemic on these trends	12
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases	12
Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts	12
New advances on the interaction between internal and external factors in the tumor microenvironment of solid tumors	12
Cofactor functions of magnesium in complement activation and antimicrobial responses	12

At the cutting-edge: what’s the latest in imaging to diagnose Sjögren’s disease?	12
Induction of aquaporins by plasma of patients with systemic lupus erythematosus	12
State of art and future challenges to early intervention, and management in patients with psoriasis at increased risk of transition to psoriatic arthritis: a review	12
Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency	12
What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?	12
Immunology and targeted therapy in Castleman disease	12
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies	12
The role of interleukin-15 in the spectrum of inflammatory diseases	11
Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis	11
B cell depletion and inhibition in systemic lupus erythematosus	11
How does sleep influence asthma through immunity?	11
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials	11
The role of serological biomarkers in the diagnosis and management of autoimmune pancreatitis	11
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine	11
Guidance for stem cell therapy for juvenile systemic sclerosis patients	11
Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review	11
Pediatric IgG4-related disease: a descriptive review	11
Basophil activation test in the food allergy clinic: its current use and future applications	11
The interaction between innate immunity and oral microbiota in oral diseases	11
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy	11
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications	10
Update on virus-induced asthma exacerbations	10
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience	10
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation	10
Individual differences in response to dust-mite-allergen specific immunotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials	10
An update on VEXAS syndrome	10
Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease	10
Role of tight junction proteins in shaping the immune milieu of malignancies	10
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies	10
Dysautonomia in systemic lupus erythematosus: when to suspect and how to investigate	10
Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects	10
A review of disease burden and clinical management for generalized pustular psoriasis in China	10
Sequential immunotherapy for alopecia areata: phase-driven immune rebalancing	10
The elusive link: EBV in MS	10
Systemic therapy in juvenile localized scleroderma	10
The clinical role of anakinra in the armamentarium against familial Mediterranean fever	10
Transglutaminase 2 in chronic inflammation and fibrosis – a potential novel therapy for stricturing Crohn’s disease	10
Potential approaches in repairing the damaged epithelial barrier in eosinophilic esophagitis	10
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors	10
An evaluation of anifrolumab for use in adults with systemic lupus erythematosus	10
Vascular endothelial dysfunction in pediatric rheumatic diseases: a systematic review and meta-analysis	10
The relationship between interleukin 17A rs2275913 gene polymorphism and circulating IL17A levels and disease activity and severity in Egyptian rheumatoid arthritis patients	10
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective	9
Considerations for managing elderly patients with atopic dermatitis	9
Mechanisms and therapeutic potential of epithelial-immune crosstalk in airway inflammation	9
Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options	9
Interleukin-33/ST2 axis in Kawasaki disease: biology, vascular pathology, and future therapeutic strategies	9
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons	9
Management and treatment optimization of patients with mild to moderate ulcerative colitis	9
Biomarkers for systemic lupus erythematosus – a focus on organ damage	9
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges	9
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge	9
The emerging role of IL-23 in asthma and its clinical implications	9
Asthma and neurodevelopmental and mental health disorder (NMD) multimorbidity in rural children	9
Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update	9
An update on our understanding of host defense mechanisms at the ocular surface; innate immune dysregulation at the ocular surface: lessons from Stevens–Johnson syndrome and related inflammatory disor	9
Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies	8
Editorial for exploring understudied inflammatory diseases	8
Toward precision in psoriatic arthritis: addressing the challenge of difficult-to-treat disease	8
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults	8
Development of a method of nasal secretions sampling for local nasal inflammation studies	8
The burden of mental health issues in Behçet’s disease: implications for patient quality of life	8
The clinical management of adult patients with Familial Mediterranean fever	8
Revisiting an immunoneuropsychiatry classic: Sydenham’s chorea	8
Clinical and immunologic implication of neo-osteogenesis in chronic rhinosinusitis	8
Primary biliary cholangitis: current insights and novel therapies	8
Potential interactions between STING pathway and the complement system in immune regulation	8
AQP9 weakens the cytotoxicity of CD8 + T cells in colon adenocarcinoma by boosting M2 polarization of macrophages under hypoxia conditions	8
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review	8
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in dermatology: cutaneous adverse events and emerging efficacy in inflammatory skin diseases	8
The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review	8
Rhupus syndrome: current knowledge and future perspectives	8
A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease	8
Evaluating the role of lung ultrasound in the diagnosis of rheumatoid arthritis-interstitial lung disease	8
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population	8
Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature	8
Decoding T and B cell dynamics in inborn errors of immunity: insights into immune dysfunction	8
TBXAS1 deficiency: a novel monogenic cause of chronic nonbacterial osteomyelitis responsive to COX inhibitors	8
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency	8
Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients	8

The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease	7
A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps	7
Comparative efficacy of systemic treatments for atopic dermatitis in adults	7
Unmet needs in the management of giant cell arteritis and polymyalgia rheumatica	7
Navigating obstetric antiphospholipid syndrome: pathophysiology, diagnosis, and therapeutic advances	7
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis	7
The pathophysiology of MASLD: an immunometabolic perspective	7
Nipocalimab for the treatment of moderate-to-severe Sjögren’s disease: a plain language summary of the DAHLIAS study	7
Re-envisioning clinical trial design in systemic sclerosis	7
Innovative treatments for severe uncontrolled chronic rhinosinusitis with nasal polyps	7
A new approach and conceptual model for understanding systemic sclerosis-associated gastrointestinal symptoms	7
Inflammation resolution and specialized pro-resolving lipid mediators in chronic rhinosinusitis	7
The relationship between MMP-2 and TIMP-2 gene polymorphisms and skin barrier function, inflammatory cytokine levels in acne patients	7
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis	7
Genetic syndromes and autoimmunity: what do we know? Focus on Down and Turner syndrome	7
Central nervous system immunological complications of immunotherapy in pediatrics	7
Unmasking cancer’s silent saboteurs: T regulatory cells as therapeutic targets in immunotherapy	7
Use of leflunomide for the management of ocular mucous membrane pemphigoid: a multicentric retrospective cohort study	7
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?	7
IL-10: the master immunomodulatory cytokine in allergen immunotherapy	7
Immunology of heart failure with preserved ejection fraction	7
Thyroid eye disease in the biologic era: a 40-year paradigm shift in nonsurgical therapeutic strategies	7
Managing acute COVID-19 in immunocompromised pediatric patients	7
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus	6
Subcutaneous immunoglobulin 20% (Ig20Gly) treatment regimens in pediatric patients with primary immunodeficiencies – real-world data from the IG TATRY study	6
Recent advances in the pathogenesis of neuropsychiatric systemic lupus erythematosus	6
Personalizing therapy selection in inflammatory bowel disease	6
Correction	6
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus	6
Telemedicine beyond the pandemic: challenges in the pediatric immunology clinic	6
Innovative surgical approaches for chronic rhinitis: nasal neurectomy mechanisms, techniques, and clinical outcomes	6
An evaluation of the recently approved drugs for treating atopic dermatitis in the context of their safety and efficacy: a systematic review and meta-analysis	6
What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?	6
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis	6
The oft-overlooked cardiovascular complications of inflammatory bowel disease	6
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments	6
Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata	6
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours	6
Probiotics in asthma management: fiction or truth?	6
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy	6
Should esophageal string test be used to monitor inflammation in EoE?	6
Recent insights into the impacts of COVID-19 on pediatric asthma	6
Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens	6
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease	6
Past, present and future of lupus nephritis	6
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis	5
Update on the pathophysiology and treatment of diabetic kidney disease: a narrative review	5
Can we identify patients at risk of severe reactions to food?	5
Genes vs environment in inflammatory bowel disease: an update	5
An update on biologic treatments for neuromyelitis optica spectrum disorder	5
Diagnosis and management of systemic sclerosis-related calcinosis	5
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making	5
Myocardial involvement in inflammatory myopathies: from subclinical disease to life-threatening myocarditis	5
Biologics for chronic spontaneous urticaria: toward a personalized treatment	5
Correction	5
Drug therapies and immune pathways in ocular manifestations of inflammatory skin diseases	5
Preventing fibrosis in IBD: update on immune pathways and clinical strategies	5
Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease	5
Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA)	5
Behçet disease: epidemiology, classification criteria and treatment modalities	5
What is the best way to plan a 12-month clinical drug trial in JIA associated uveitis?	5
Chronic rhinosinusitis disease control: a review of the history and the evidence	5
Exploring the relationship between house dust mites and asthma	5
New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis	5
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy	5
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition	5
Exploring treatment options for pediatric refractory chronic urticaria	5
Upadacitinib for moderate-to-severe atopic dermatitis, in adults and adolescents 12 years and older: review of international and Japanese populations	5
Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis	5
A review of berotralstat for the treatment of hereditary angioedema	5
Combination immunotherapy for pancreatic cancer: challenges and future considerations	5
Climate change and the immune system	5
Neuro-ophthalmic challenges and multi-morbidity in vasculitis among the older adults	5
Avacopan for the treatment of ANCA-associated vasculitis: an update	5
Single-cell RNA sequencing: an emerging tool revealing dysregulated innate and adaptive immune response at single cell level in Kawasaki disease	5
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum aut	5
Topical roflumilast for the treatment of psoriasis	4
Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation	4
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives	4
Role of CD68 in the tumor immune microenvironment in Hodgkin’s lymphoma	4
Flow cytometry-based basophil and mast cell activation tests for IgE-mediated food and drug allergy: have we crossed the Rubicon?	4
The role of nasal cytology in the diagnosis and treatment of Allergic rhinitis	4
Secukinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients aged six years and older	4
Machine learning method for the cellular phenotyping of nasal polyps from multicentre tissue scans	4
Filgotinib in rheumatoid arthritis	4
Mechanisms of resistance to adoptive cell therapy with tumor-infiltrating lymphocytes	4
Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome	4
Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies	4
Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity	4
Association between inactivated COVID-19 vaccine and semen quality among males recovered from omicron infection: a retrospective cohort study	4
Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review	4
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma	4
The relationship between bullous pemphigoid and renal disease and related treatments: a review of the current literature	4
Why do drug treatments fail in Sjögren’s disease? Considerations for treatment, trial design and interpretation of clinical efficacy	4
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation	4